Tampa, FL, United States of America

J Edward Semple

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 5 CIPO patents and 3 EPO patents. Top assignee: Romark Laboratories L.c.. Active years: 2012-2023.

USPTO Granted Patents = 13 

% Patents Active = 53.8

 

 

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 101(Granted Patents)


Location History:

  • Tampa, DE (US) (2014)
  • Tampa, FL (US) (2012 - 2023)

Company Filing History:


Years Active: 2012-2023

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: J Edward Semple: Innovator in Influenza Treatment

Introduction

J Edward Semple is a notable inventor based in Tampa, FL, who has made significant contributions to the field of medicine, particularly in the treatment of influenza. With a total of 13 patents to his name, Semple's work focuses on innovative methods and compounds aimed at combating viral infections.

Latest Patents

Among his latest patents, Semple has developed compounds and methods for treating influenza. This invention is directed to methods for treating and preventing influenza infection by inhibiting influenza virus HA maturation processes employing compounds of formula I. It is also directed to combinations for treating and preventing influenza infection comprising compounds of formula I and other agents.

Career Highlights

Semple's career is marked by his dedication to research and development in the pharmaceutical industry. He is currently associated with Romark Laboratories L.C., where he continues to innovate and contribute to advancements in medical treatments.

Collaborations

One of his notable collaborators is Jean-Francois Rossignol, with whom he has worked on various projects aimed at enhancing the efficacy of influenza treatments.

Conclusion

J Edward Semple's contributions to the field of influenza treatment through his innovative patents and collaborations highlight his commitment to improving public health. His work continues to pave the way for new therapeutic options in the fight against viral infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…